Erythromycin reduces nasal inflammation by inhibiting immunoglobulin production, attenuating mucus secretion, and modulating cytokine expression

Allergic rhinitis (AR) and chronic rhinosinusitis (CRS) share some similar pathological mechanisms. In current study, we intend to investigate the impact of AR on CRS. In addition, we explored the efficacy of erythromycin (EM) treatment on CRS mice with or without AR (CRSwoAR, CRSwAR). Study subject...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Ting-Ting, Jiang, Rong-San, Chang, Ching-Yun, Wu, Chih-Ying, Liang, Kai-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571277/
https://www.ncbi.nlm.nih.gov/pubmed/34741083
http://dx.doi.org/10.1038/s41598-021-01192-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571277/
https://www.ncbi.nlm.nih.gov/pubmed/34741083
http://dx.doi.org/10.1038/s41598-021-01192-8

Ejemplares similares